LT1981872T - Bifenil-2-ilkarbamo rūgšties 1-[2-(2-chlor-4-{[(r)-2-hidroksi-2-(8-hidroksi-2-okso-1,2-dihidrochinolin-5-il)etilamino]metil]}-5-metoksifenilkarbamoil)etil]piperidin-4-ilo esterio gintaro rūgšties druska ir jos naudojimas plaučių susirgimų gydymui - Google Patents

Bifenil-2-ilkarbamo rūgšties 1-[2-(2-chlor-4-{[(r)-2-hidroksi-2-(8-hidroksi-2-okso-1,2-dihidrochinolin-5-il)etilamino]metil]}-5-metoksifenilkarbamoil)etil]piperidin-4-ilo esterio gintaro rūgšties druska ir jos naudojimas plaučių susirgimų gydymui

Info

Publication number: LT1981872T
Authority: LT; Lithuania
Prior art keywords: hydroxy; ylaminoimethyl; ylester; methoxyphenylcarbamoyl; diso
Prior art date: 2006-02-10

Application number

LTEP07704449.3T

Other languages

English (en)

Inventor

Reshma Chudasama

Andrew Kennedy

Leanda Jane Kindon

Franck Patrick Mallet

Original Assignee

Glaxo Group Limited

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-02-10

Filing date

2007-02-08

Publication date

2017-09-11

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36119909&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LT1981872(T) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2007-02-08 Application filed by Glaxo Group Limited filed Critical Glaxo Group Limited

2017-09-11 Publication of LT1981872T publication Critical patent/LT1981872T/lt

Links

QMOVGVNKXUTCQU-UHFFFAOYSA-N (2-phenylphenyl)carbamic acid Chemical compound OC(=O)NC1=CC=CC=C1C1=CC=CC=C1 QMOVGVNKXUTCQU-UHFFFAOYSA-N 0.000 title 1
-1 8-hydroxy-2-oxo-1, 2-dihydroquinolin-5-yl Chemical group 0.000 title 1
125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 title 1
230000002685 pulmonary effect Effects 0.000 title 1
KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical class OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Pulmonology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Hydrogenated Pyridines (AREA)

LTEP07704449.3T 2006-02-10 2007-02-08 Bifenil-2-ilkarbamo rūgšties 1-[2-(2-chlor-4-{[(r)-2-hidroksi-2-(8-hidroksi-2-okso-1,2-dihidrochinolin-5-il)etilamino]metil]}-5-metoksifenilkarbamoil)etil]piperidin-4-ilo esterio gintaro rūgšties druska ir jos naudojimas plaučių susirgimų gydymui LT1981872T (lt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB0602778.3A GB0602778D0 (en)	2006-02-10	2006-02-10	Novel compound
PCT/EP2007/051196 WO2007090859A1 (en)	2006-02-10	2007-02-08	Succinic acid salt of biphenyl-2-ylcarbamic acid 1-[2-(2-chloro-4-{ [ (r)-2-hydroxy-2- (8-hydroxy-2-oxo-1, 2-dihydroquinolin-5-yl) eth ylaminoimethyl] } -5-methoxyphenylcarbamoyl) ethyl] piperidin-4-yl ester and its use for the treatment of pulmonary disorders

Publications (1)

Publication Number	Publication Date
LT1981872T true LT1981872T (lt)	2017-09-11

Family

ID=36119909

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
LTEP07704449.3T LT1981872T (lt)	2006-02-10	2007-02-08	Bifenil-2-ilkarbamo rūgšties 1-[2-(2-chlor-4-{[(r)-2-hidroksi-2-(8-hidroksi-2-okso-1,2-dihidrochinolin-5-il)etilamino]metil]}-5-metoksifenilkarbamoil)etil]piperidin-4-ilo esterio gintaro rūgšties druska ir jos naudojimas plaučių susirgimų gydymui

Country Status (33)

Country	Link
US (1)	US7960551B2 (lt)
EP (1)	EP1981872B1 (lt)
JP (1)	JP5616021B2 (lt)
KR (1)	KR101488691B1 (lt)
CN (1)	CN101379057B (lt)
AR (2)	AR059409A1 (lt)
AU (1)	AU2007213767B2 (lt)
BR (1)	BRPI0707559B8 (lt)
CA (1)	CA2641769C (lt)
CR (1)	CR10227A (lt)
CY (1)	CY1119238T1 (lt)
DK (1)	DK1981872T3 (lt)
EA (1)	EA016580B1 (lt)
ES (1)	ES2640226T3 (lt)
GB (1)	GB0602778D0 (lt)
HR (1)	HRP20171304T1 (lt)
HU (1)	HUE034315T2 (lt)
IL (1)	IL193103A (lt)
JO (1)	JO3389B1 (lt)
LT (1)	LT1981872T (lt)
MA (1)	MA30273B1 (lt)
MY (1)	MY153656A (lt)
NO (1)	NO341343B1 (lt)
NZ (1)	NZ570242A (lt)
PE (2)	PE20110120A1 (lt)
PL (1)	PL1981872T3 (lt)
PT (1)	PT1981872T (lt)
SG (1)	SG169404A1 (lt)
SI (1)	SI1981872T1 (lt)
TW (1)	TWI401251B (lt)
UA (1)	UA100364C2 (lt)
WO (1)	WO2007090859A1 (lt)
ZA (1)	ZA200806782B (lt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP5540075B2 (ja) *	2009-04-14	2014-07-02	グラクソグループリミテッド	ビフェニル−２−イルカルバミン酸エステルの調製方法
AU2015234331B2 (en) *	2009-04-23	2017-08-03	Theravance Biopharma R&D Ip, Llc	Diamide compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity
MX2011011156A (es) *	2009-04-23	2011-11-04	Theravance Inc	COMPUESTOS DIAMIDA QUE TIENE ACTIVIDAD COMO ANTAGONISTAS DE LOS RECEPTORES MUSCARINICOS Y COMO AGONISTAS DE LOS RECEPTORES ANDRENERGICOS ß2.
WO2011081937A1 (en)	2009-12-15	2011-07-07	Gilead Sciences, Inc.	Corticosteroid-beta-agonist-muscarinic antagonist compounds for use in therapy
ITRM20110083U1 (it)	2010-05-13	2011-11-14	De La Cruz Jose Antonio Freire	Piastra per la costruzione di carrelli per aeroplani
EP2386555A1 (en)	2010-05-13	2011-11-16	Almirall, S.A.	New cyclohexylamine derivatives having beta2 adrenergic agonist and m3 muscarinic antagonist activities
AR083115A1 (es) *	2010-09-30	2013-01-30	Theravance Inc	Sales oxalato cristalinas de un compuesto diamida
JP6019118B2 (ja) *	2011-08-02	2016-11-02	シグマ−タウ・インドゥストリエ・ファルマチェウチケ・リウニテ・ソシエタ・ペル・アチオニＳｉｇｍａ−ＴａｕＩｎｄｕｓｔｒｉｅＦａｒｍａｃｅｕｔｉｃｈｅＲｉｕｎｉｔｅＳｏｃｉｅｔａＰｅｒＡｚｉｏｎｉ	吸入に適した酸化型アビジンの医薬品組成物
EP2592078A1 (en)	2011-11-11	2013-05-15	Almirall, S.A.	New cyclohexylamine derivatives having beta2 adrenergic agonist and M3 muscarinic antagonist activities
MA38260B1 (fr)	2012-12-18	2018-04-30	Almirall Sa	Nouveaux dérivés de cyclohexyl et quinuclidinyl carbamate ayant une activité d'agoniste adrénergique beta2 et une activité d'antagoniste muscarinique m3
TWI643853B (zh)	2013-02-27	2018-12-11	阿爾米雷爾有限公司	同時具有β2腎上腺素受體促效劑和M3毒蕈鹼受體拮抗劑活性之2-氨基-1-羥乙基-8-羥基喹啉-2(1H)-酮衍生物之鹽類
TW201517906A (zh)	2013-07-25	2015-05-16	Almirall Sa	含有ｍａｂａ化合物和皮質類固醇之組合
TWI641373B (zh)	2013-07-25	2018-11-21	阿爾米雷爾有限公司	具有蕈毒鹼受體拮抗劑和β２腎上腺素受體促效劑二者之活性的２－胺基－１－羥乙基－８－羥基喹啉－２（１Ｈ）－酮衍生物之鹽
TW201617343A (zh)	2014-09-26	2016-05-16	阿爾米雷爾有限公司	具有β２腎上腺素促效劑及Ｍ３蕈毒拮抗劑活性之新穎雙環衍生物
GB201500447D0 (en) *	2015-01-12	2015-02-25	Glaxosmithkline Ip Dev Ltd	Novel Combination Product
CN106632257B (zh) *	2016-12-15	2019-02-12	上海市奉贤区中心医院	Gsk961081及其中间体的合成方法
US11484531B2 (en)	2018-08-30	2022-11-01	Theravance Biopharma R&D Ip, Llc	Methods for treating chronic obstructive pulmonary disease

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4026897A (en) *	1974-01-31	1977-05-31	Otsuka Pharmaceutical Company	5-[1-Hydroxy-2-(substituted-amino)]alkyl-8-hydroxycarbostyril derivatives
DE3134590A1 (de)	1981-09-01	1983-03-10	Boehringer Ingelheim KG, 6507 Ingelheim	Neue benzo-heterocyclen
US4460581A (en) *	1982-10-12	1984-07-17	Boehringer Ingelheim Kg	(1-Hydroxy-2-amino-alkyl)-substituted benzoxazinones and benzoxazolinones
ZW6584A1 (en) *	1983-04-18	1985-04-17	Glaxo Group Ltd	Phenethanolamine derivatives
US4894219A (en) *	1988-03-29	1990-01-16	University Of Florida	Beta-agonist carbostyril derivatives, assay method and pharmacological composition
DK443489D0 (da)	1989-09-08	1989-09-08	Ferrosan As	Substituerede urinstofforbindelser, deres fremstilling og anvendelse
CA2133083A1 (en)	1992-03-31	1993-10-14	Alexander W. Oxford	Substituted phenylcarbamates and phenylureas, their preparation and their use as 5-ht antagonists
CA2123728A1 (en) *	1993-05-21	1994-11-22	Noriyoshi Sueda	Urea derivatives and their use as acat inhibitors
WO1995006635A1 (en)	1993-09-02	1995-03-09	Yamanouchi Pharmaceutical Co., Ltd.	Carbamate derivative and medicine containing the same
AU685225B2 (en)	1994-02-10	1998-01-15	Yamanouchi Pharmaceutical Co., Ltd.	Novel carbamate derivative and medicinal composition containing the same
ATE205490T1 (de)	1995-10-13	2001-09-15	Banyu Pharma Co Ltd	Substituierte heteroaromatische derivate
PE92198A1 (es)	1996-08-01	1999-01-09	Banyu Pharma Co Ltd	Derivados de 1,4-piperidina disustituida que contienen fluor
US6040344A (en) *	1996-11-11	2000-03-21	Sepracor Inc.	Formoterol process
CA2313125A1 (en)	1997-12-12	1999-06-24	Laramie Mary Gaster	Quinolinepiperazine and quinolinepiperidine derivatives, their preparation and their use as combined 5-ht1a, 5-ht1b and 5-ht1d receptor antagonists
US6713651B1 (en) *	1999-06-07	2004-03-30	Theravance, Inc.	β2-adrenergic receptor agonists
WO1999064043A1 (en)	1998-06-08	1999-12-16	Advanced Medicine, Inc.	Muscarinic receptor antagonists
US6541669B1 (en) *	1998-06-08	2003-04-01	Theravance, Inc.	β2-adrenergic receptor agonists
US6693202B1 (en) *	1999-02-16	2004-02-17	Theravance, Inc.	Muscarinic receptor antagonists
GB9913083D0 (en)	1999-06-04	1999-08-04	Novartis Ag	Organic compounds
US6593497B1 (en) *	1999-06-02	2003-07-15	Theravance, Inc.	β2-adrenergic receptor agonists
DE60021282T2 (de)	1999-12-07	2006-05-18	Theravance, Inc., South San Francisco	Carbamat-derivate als muscarin-rezeptor antonisten
UA73543C2 (uk) *	1999-12-07	2005-08-15	Тераванс, Інк.	Похідні сечовини, фармацевтична композиція та застосування похідного при приготуванні лікарського засобу для лікування захворювання, яке опосередковується мускариновим рецептором
UA73965C2 (en) *	1999-12-08	2005-10-17	Theravance Inc	b2 ADRENERGIC RECEPTOR ANTAGONISTS
EP1248869A2 (en) *	2000-01-07	2002-10-16	Transform Pharmaceuticals, Inc.	High-throughput formation, identification, and analysis of diverse solid-forms
NZ522882A (en)	2000-06-05	2004-07-30	Altana Pharma Bv	Pyridazinone compounds effective as beta-2-adrenoreceptor agonists as well as PDE4-inhibitors
NZ526580A (en)	2000-12-22	2005-04-29	Almirall Prodesfarma Ag	Quinuclidine carbamate derivatives and their use as M3 antagonists
GB0103630D0 (en)	2001-02-14	2001-03-28	Glaxo Group Ltd	Chemical compounds
US20030018019A1 (en) *	2001-06-23	2003-01-23	Boehringer Ingelheim Pharma Kg	Pharmaceutical compositions based on anticholinergics, corticosteroids and betamimetics
TWI249515B (en) *	2001-11-13	2006-02-21	Theravance Inc	Aryl aniline beta2 adrenergic receptor agonists
US6653323B2 (en) *	2001-11-13	2003-11-25	Theravance, Inc.	Aryl aniline β2 adrenergic receptor agonists
MXPA04009916A (es)	2002-04-12	2005-05-03	Boehringer Ingelheim Pharma	Medicamento que contiene betamimeticos y un nuevo anticolinergico.
WO2003099764A1 (en) *	2002-05-28	2003-12-04	Theravance, Inc.	ALKOXY ARYL β2 ADRENERGIC RECEPTOR AGONISTS
GB0217225D0 (en)	2002-07-25	2002-09-04	Glaxo Group Ltd	Medicinal compounds
TW200410951A (en)	2002-08-06	2004-07-01	Glaxo Group Ltd	M3 muscarinic acetylcholine receptor antagonists
PE20040950A1 (es) *	2003-02-14	2005-01-01	Theravance Inc	DERIVADOS DE BIFENILO COMO AGONISTAS DE LOS RECEPTORES ADRENERGICOS ß2 Y COMO ANTAGONISTAS DE LOS RECEPTORES MUSCARINICOS
JP4767842B2 (ja)	2003-04-01	2011-09-07	セラヴァンス，インコーポレーテッド	β２アドレナリン作用性レセプターアゴニスト活性およびムスカリン性レセプターアンタゴニスト活性を有するジアリールメチル化合物および関連化合物
DE602004021921D1 (de) *	2003-05-28	2009-08-20	Theravance Inc	Azabicycloalkanverbindungen als muscarinrezeptor antagonisten
ES2329586T3 (es) *	2003-11-21	2009-11-27	Theravance, Inc.	Compuestos que tienen actividad agonista del receptor beta2 adrenergico y antagonista del receptor muscarino.
WO2005080375A1 (en) *	2004-02-13	2005-09-01	Theravance, Inc.	Crystalline form of a biphenyl compound
TWI374883B (en) *	2004-08-16	2012-10-21	Theravance Inc	Crystalline form of a biphenyl compound
WO2006023457A1 (en) *	2004-08-16	2006-03-02	Theravance, Inc.	COMPOUNDS HAVING β2 ADRENERGIC RECEPTOR AGONIST AND MUSCARINIC RECEPTOR ANTAGONIST ACTIVITY
WO2006023460A2 (en) *	2004-08-16	2006-03-02	Theravance, Inc.	COMPOUNDS HAVING β2 ADRENERGIC RECEPTOR AGONIST AND MUSCARINIC RECEPTOR ANTAGONIST ACTIVITY

2006
- 2006-02-10 GB GBGB0602778.3A patent/GB0602778D0/en not_active Ceased
2007
- 2007-02-08 CA CA2641769A patent/CA2641769C/en active Active
- 2007-02-08 HU HUE07704449A patent/HUE034315T2/en unknown
- 2007-02-08 TW TW096104636A patent/TWI401251B/zh not_active IP Right Cessation
- 2007-02-08 PE PE2010000996A patent/PE20110120A1/es active IP Right Grant
- 2007-02-08 AU AU2007213767A patent/AU2007213767B2/en not_active Ceased
- 2007-02-08 ES ES07704449.3T patent/ES2640226T3/es active Active
- 2007-02-08 EA EA200801691A patent/EA016580B1/ru unknown
- 2007-02-08 CN CN2007800050282A patent/CN101379057B/zh not_active Expired - Fee Related
- 2007-02-08 LT LTEP07704449.3T patent/LT1981872T/lt unknown
- 2007-02-08 SG SG201100933-9A patent/SG169404A1/en unknown
- 2007-02-08 EP EP07704449.3A patent/EP1981872B1/en active Active
- 2007-02-08 DK DK07704449.3T patent/DK1981872T3/en active
- 2007-02-08 WO PCT/EP2007/051196 patent/WO2007090859A1/en not_active Ceased
- 2007-02-08 KR KR20087022160A patent/KR101488691B1/ko not_active Expired - Fee Related
- 2007-02-08 PE PE2007000135A patent/PE20071249A1/es not_active Application Discontinuation
- 2007-02-08 JP JP2008553758A patent/JP5616021B2/ja not_active Expired - Fee Related
- 2007-02-08 SI SI200731963T patent/SI1981872T1/sl unknown
- 2007-02-08 PL PL07704449T patent/PL1981872T3/pl unknown
- 2007-02-08 HR HRP20171304TT patent/HRP20171304T1/hr unknown
- 2007-02-08 BR BRPI0707559A patent/BRPI0707559B8/pt not_active IP Right Cessation
- 2007-02-08 US US11/672,536 patent/US7960551B2/en active Active
- 2007-02-08 NZ NZ570242A patent/NZ570242A/en not_active IP Right Cessation
- 2007-02-08 PT PT77044493T patent/PT1981872T/pt unknown
- 2007-02-08 AR ARP070100537A patent/AR059409A1/es not_active Application Discontinuation
- 2007-02-08 JO JOP/2007/0037A patent/JO3389B1/ar active
- 2007-08-02 UA UAA200809940A patent/UA100364C2/ru unknown
2008
- 2008-07-29 IL IL193103A patent/IL193103A/en active IP Right Grant
- 2008-08-05 NO NO20083425A patent/NO341343B1/no unknown
- 2008-08-05 ZA ZA200806782A patent/ZA200806782B/xx unknown
- 2008-08-08 MY MYPI20083025A patent/MY153656A/en unknown
- 2008-08-20 CR CR10227A patent/CR10227A/es not_active Application Discontinuation
- 2008-09-10 MA MA31228A patent/MA30273B1/fr unknown
2016
- 2016-04-15 AR ARP160101036A patent/AR104288A2/es not_active Application Discontinuation
2017
- 2017-08-22 CY CY20171100887T patent/CY1119238T1/el unknown

Also Published As

Publication number	Publication date
TW200800948A (en)	2008-01-01
AR104288A2 (es)	2017-07-12
US7960551B2 (en)	2011-06-14
UA100364C2 (xx)	2012-12-25
PE20071249A1 (es)	2008-01-16
BRPI0707559B8 (pt)	2021-05-25
KR20080114723A (ko)	2008-12-31
IL193103A (en)	2013-06-27
SG169404A1 (en)	2011-03-30
BRPI0707559B1 (pt)	2021-01-12
ZA200806782B (en)	2009-10-28
MA30273B1 (fr)	2009-03-02
EP1981872A1 (en)	2008-10-22
AR059409A1 (es)	2008-04-09
HRP20171304T1 (hr)	2017-10-20
JP5616021B2 (ja)	2014-10-29
CN101379057B (zh)	2013-02-13
ES2640226T3 (es)	2017-11-02
EA016580B1 (ru)	2012-06-29
SI1981872T1 (sl)	2017-10-30
NO341343B1 (no)	2017-10-16
US20070281971A1 (en)	2007-12-06
CR10227A (es)	2008-10-29
MY153656A (en)	2015-03-13
WO2007090859A1 (en)	2007-08-16
DK1981872T3 (en)	2017-09-11
PE20110120A1 (es)	2011-03-08
CY1119238T1 (el)	2018-02-14
JO3389B1 (ar)	2019-03-13
JP2009526018A (ja)	2009-07-16
NZ570242A (en)	2011-09-30
EP1981872B1 (en)	2017-06-21
TWI401251B (zh)	2013-07-11
CA2641769C (en)	2014-02-04
BRPI0707559A2 (pt)	2011-05-10
CN101379057A (zh)	2009-03-04
NO20083425L (no)	2008-09-09
KR101488691B1 (ko)	2015-02-02
GB0602778D0 (en)	2006-03-22
EA200801691A1 (ru)	2009-02-27
PT1981872T (pt)	2017-09-13
CA2641769A1 (en)	2007-08-16
PL1981872T3 (pl)	2017-11-30
AU2007213767A1 (en)	2007-08-16
AU2007213767B2 (en)	2012-04-26
BRPI0707559A8 (pt)	2019-01-29
HUE034315T2 (en)	2018-02-28
IL193103A0 (en)	2009-02-11

Publication	Publication Date	Title
LT1981872T (lt)	2017-09-11	Bifenil-2-ilkarbamo rūgšties 1-[2-(2-chlor-4-{[(r)-2-hidroksi-2-(8-hidroksi-2-okso-1,2-dihidrochinolin-5-il)etilamino]metil]}-5-metoksifenilkarbamoil)etil]piperidin-4-ilo esterio gintaro rūgšties druska ir jos naudojimas plaučių susirgimų gydymui
IL192241A0 (en)	2008-12-29	Improved process for the preparation of 4-(benzimidazolylmethylamino)-benzamides and the salts thereof
IL199397A (en)	2014-07-31	Hetero-ring compounds, pharmaceuticals containing them, and their medicinal products
IL196571A0 (en)	2009-11-18	N-(aminoheteroaryl)-1h-indole-2-carboxamide derivatives, and preparation and therapeutic application thereof
IL196113A0 (en)	2009-09-01	N-(aminoheteroaryl)-1h-indole-2-carboxamide derivatives, preparation thereof and therapeutic use thereof
ZA200805608B (en)	2009-12-30	Fungicide n-cycloalkyl benzyl amide derivatives
BR112012003462A2 (pt)	2016-02-23	"composto, composição farmacêutica, e, método para tratar um paciente tendo uma condição mediada pela proteína quinase."
BRPI0905388A2 (pt)	2015-10-13	"composição farmacêutica; compostos e métodos de tratamento de infecção por arenavirus"
PL2401263T3 (pl)	2016-08-31	Podstawione pochodne azotu, zawierająca pochodne kompozycja farmaceutyczna, i sposób leczenia choroby Parkinsona przy ich użyciu
IL181607A0 (en)	2007-07-04	Novel process for preparing montelukast and salts thereof
PL2583555T3 (pl)	2015-10-30	Zastosowanie kompozycji o działaniu biobójczym do preparatów wodnych oraz sposób stabilizowania względem bakterii takich preparatów wodnych
IL202235A (en)	2015-03-31	Amides and thioamides of 2-phenyl-ethyl-amino-acid, their history and their pharmaceutical preparations
ZA200900895B (en)	2010-05-26	Family of pliers for clamping plates having similar and preferably identical frames, and pliers from such family
PT2231598E (pt)	2011-10-11	Novos derivados diazéniodiolato, processo para a sua preparação e as composições farmacêuticas que os contenham
EP2069307A4 (en)	2010-03-03	PROCESS FOR THE PREPARATION OF MONTELUKAST AND ITS SALTS
EP2059783A4 (en)	2016-03-09	COMPOSITION AND METHOD FOR HANDLING TISSUE SAMPLES
EP2119436A4 (en)	2010-03-03	PHARMACEUTICAL COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF EYE DISEASES
EP2163244A4 (en)	2011-12-21	MEDIUM, PHARMACEUTICAL COMPOSITION AND METHOD FOR TREATING THE DEPENDENCE OF ETHYL ALCOHOL OR NARCOTICS
ZA200804492B (en)	2009-08-26	S-Omeprazole strontium or hydrate thereof, method for preparing same, and pharmaceutical composition comprising same
PT2220047E (pt)	2015-07-30	Derivados de quinolina, composições farmacêuticas que os contêm e sua utilização
ZA200809565B (en)	2009-09-30	4-(2, e-dichloro-benzoylamino)-1H-pyrazole-s-carboxylic acid (1-methanesulphonyl-piperidin-4-yl)-amide for the treatment of cancer
IL205981A0 (en)	2010-11-30	15,16-METHYLENE-17-HYDROXY-19-NOR-21-CARBOXYLIC ACID ã?-LACTONE DERIVATIVE , USE THEREOF, AND MEDICAMENT CONTAINING SAID DERIVATIVE
PL2142499T3 (pl)	2015-05-29	Podstawione sulfonamidy, sposób ich wytwarzania, zawierająca je kompozycja farmaceutyczna oraz ich zastosowanie do leczenia jaskry
PL2119700T3 (pl)	2013-01-31	Pochodna benzyloaminy lub jej farmaceutycznie dopuszczalna sól addycyjna z kwasem oraz ich zastosowanie do celów medycznych
HUP0600726A3 (en)	2008-07-28	N-(phenalkylamino-alkyl)-carboxylic acid amides, process for their preparation, their use and pharmaceutical compositions containing the same